Table 3.
Non-OSA | OSA | p | |||
---|---|---|---|---|---|
N=25 | N=19 | ||||
N | % | N | % | ||
Craniofacial abnormalities | 20 | 80.0% | 13 | 68.4% | 0.380 |
Pharyngeal abnormalities | 2 | 8.0% | 0 | 0.0% | 0.207 |
Nasal abnormalities | 15 | 60.0% | 10 | 52.6% | 0.625 |
Hypertrophic palatine tonsils | 6 | 24.0% | 14 | 73.7% | 0.001* |
Hypertrophic pharyngeal tonsil | 11 | 44.0% | 14 | 73.7% | 0.049* |
MMI classes III / IV | 15 | 60.0% | 16 | 84.2% | 0.081** |
OSA=group with obstructive sleep apnea; Non-OSA=group without obstructive sleep apnea; MMI=modified Mallampati index,
p=statistical value (p<0.05),
p=statistical value (0.10 < p≤0.05); Chi-squared test (x2)